Loading clinical trials...

The TOGETHER Project - Liver | Clinical Trials | Clareo Health

COMPLETEDNCT03874286

The TOGETHER Project - Liver

To validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results.

Lead sponsor: Mayo Clinic•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

Active Not Recruiting

Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients

NCT06153641 · Liver Transplant Rejection, Liver Transplant Failure and Rejection

COMPLETED

Mortality, Morbidity and Risk Factors of Liver Retransplantation

NCT04789213 · Liver Transplant; Complications, Liver Transplant Rejection, and more

UNKNOWNNA

VOCs in Kidney and Liver Transplants

NCT04514666 · Liver Transplant Rejection, Kidney Transplant; Complications

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 20, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment54

Start dateMar 2017

Last updatedMay 20, 2022

Condition

Liver Transplant Rejection

Locations shown

Mayo Clinic

Phoenix, Arizona

Mayo Clinic

Jacksonville, Florida

Mayo Clinic

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 20, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The TOGETHER Project - Liver

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients

Mortality, Morbidity and Risk Factors of Liver Retransplantation

VOCs in Kidney and Liver Transplants

Trial snapshot

Condition

Locations shown

For caregivers